Cargando…

Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New

The urgent need for new therapies for some devastating neuromuscular diseases (NMDs), such as Duchenne muscular dystrophy or amyotrophic lateral sclerosis, has led to an intense search for new potential biomarkers. Biomarkers can be classified based on their clinical value into different categories:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barp, Andrea, Ferrero, Amanda, Casagrande, Silvia, Morini, Roberta, Zuccarino, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393752/ https://www.ncbi.nlm.nih.gov/pubmed/34439911 http://dx.doi.org/10.3390/biom11081246

Ejemplares similares

Cell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved
por: Shimada, Yutaka, et al.
Publicado: (2022)

Pediatric Hepatocellular Adenomas: What Is Known and What Is New?
por: Espinoza, Andres F., et al.
Publicado: (2023)

Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders
por: Barp, Andrea, et al.
Publicado: (2021)

Utilization Behavior: What Is Known and What Has to Be Known?
por: Iaccarino, Leonardo, et al.
Publicado: (2014)

Antipsychotics cardiotoxicity: What's known and what's next
por: Li, Xiao-Qing, et al.
Publicado: (2021)

Stroke and Etiopathogenesis: What Is Known?
por: Ciarambino, Tiziana, et al.
Publicado: (2022)

Parkinsonism may aggravate dysphagia in myotonic dystrophy type 1: two case reports
por: Stano, Salvatore, et al.
Publicado: (2023)

Nutritional supplementation on wound healing in diabetic foot: What is known and what is new?
por: Da Porto, Andrea, et al.
Publicado: (2022)

Hyperglycemia and COVID-19: What was known and what is really new?
por: Ceriello, Antonio
Publicado: (2020)

The Infectious Pancreatic Necrosis Virus (IPNV) and its Virulence Determinants: What is Known and What Should be Known
por: Dopazo, Carlos P.
Publicado: (2020)

Coronavirus Disease 2019 in Neonates – What Is Known and What Needs to Be Known
por: Nayak, Manas, et al.
Publicado: (2020)

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
por: Cazzaniga, Marina Elena, et al.
Publicado: (2019)

Long COVID: what is known and what gaps need to be addressed
por: Krishna, Benjamin, et al.
Publicado: (2023)

TRPA1 Role in Inflammatory Disorders: What Is Known So Far?
por: Landini, Lorenzo, et al.
Publicado: (2022)

Question what is “known”
por: Heller, H. Craig
Publicado: (2021)

What should be known prior to performing EUS?
por: Dietrich, Christoph F., et al.
Publicado: (2019)

Aetiology of biliary atresia: what is actually known?
por: Petersen, Claus, et al.
Publicado: (2013)

Relationships between Behavioural Addictions and Psychiatric Disorders: What Is Known and What Is Yet to Be Learned?
por: Starcevic, Vladan, et al.
Publicado: (2017)

Pathogenesis of multimorbidity—what is known?
por: Wetterling, Tilman
Publicado: (2020)

Sarcoptes Infestation. What Is Already Known, and What Is New about Scabies at the Beginning of the Third Decade of the 21st Century?
por: Talaga-Ćwiertnia, Katarzyna
Publicado: (2021)

Olfactory Communication via Microbiota: What Is Known in Birds?
por: Maraci, Öncü, et al.
Publicado: (2018)

Hypopituitarism after Orthohantavirus Infection: What is Currently Known?
por: Bhoelan, Soerajja, et al.
Publicado: (2019)

What Is Known about Theragnostic Strategies in Colorectal Cancer
por: Parisi, Alessandro, et al.
Publicado: (2021)

What Is Known about Breast Cancer in Young Women?
por: Zhu, Jie Wei, et al.
Publicado: (2023)

Circulating RNA in Kidney Cancer: What We Know and What We Still Suppose
por: Cinque, Alessandra, et al.
Publicado: (2021)

Ion Channels in Inflammatory Processes: What Is Known and What Is Next?
por: Retamal, Mauricio A., et al.
Publicado: (2016)

Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
por: Jiang, Chunyan, et al.
Publicado: (2023)

Intravesical bacillus Calmette-Guerin for bladder cancer: What is known? What is not? What is next?
por: Madbouly, Khaled
Publicado: (2013)

Virulence of newcastle disease virus: what is known so far?
por: Dortmans, Jos CFM, et al.
Publicado: (2011)

Antipsychotic Drugs in Prevention of Postoperative Delirium—What Is Known in 2020?
por: Pluta, Michał P., et al.
Publicado: (2020)

Severe acute hepatitis of unknown aetiology in children—what is known?
por: Khader, Susan, et al.
Publicado: (2022)

Aspergillus-SARS-CoV-2 Coinfection: What Is Known?
por: Castro-Fuentes, Carlos Alberto, et al.
Publicado: (2022)

What Is Known about Midazolam? A Bibliometric Approach of the Literature
por: Corôa, Maria Claudia Pinheiro, et al.
Publicado: (2022)

SARS-CoV-2-associated gastrointestinal and liver diseases: what is known and what is needed to explore
por: Sweed, Dina, et al.
Publicado: (2021)

Emergence of COVID-19 Infection: What Is Known and What Is to Be Expected-Narrative Review Article
por: AlTakarli, Nourah S.
Publicado: (2020)

Treatment of Extracranial Carotid Artery Aneurysms: What is Known and What is Unknown?
por: de Borst, G.J., et al.
Publicado: (2017)

Pathological Mechanisms in Diabetes of the Exocrine Pancreas: What’s Known and What’s to Know
por: Wei, Qiong, et al.
Publicado: (2020)

Laryngopharyngeal reflux concept: what is known and what should we focus on?()
por: Sirin, Seher, et al.
Publicado: (2019)

Biomarkers for Sepsis: What Is and What Might Be?
por: Biron, Bethany M., et al.
Publicado: (2015)

Reversal of neuromuscular block: what are the costs?
por: Bartels, Karsten, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_va0bs05h8q5bf68psnl836v3hr